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BSS Plus compared to the vitreous of non-diabetics and diabetics 
 
We thank Prof Sebag for the recent editorial1 which provided a critical review of our paper 
‘Biochemical Analysis of the Living Human Vitreous’.2 Our study reported the biochemical 
composition of vitreous obtained during macular hole repairs and epiretinal membrane peels, 
from both diabetic and non-diabetic individuals. Prof Sebag suggested that it would be 
interesting to compare the vitreous data from both the non-diabetic and diabetic subgroups to 
BSS Plus Irrigating Solution (Alcon, USA).3 We have under- taken this subgroup analysis 
(Table 1).  
It is known that BSS Plus does not contain a wide range of vitreous components, such as lactate, 
beta-hydroxybutyrate, copper, zinc, selenium, iron, transferrin and ferritin.2 
This study indirectly assessed the composition of vitreous, using vitreous tissue extracted 
at the time of surgery, which was then frozen until analysis. Nevertheless, this provides the 
strongest evidence so far that solute concentration discrepancies of between 3.8% and 100% 
exist between human vitreous and the vitreous substitute BSS Plus. 
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Table 1. Comparison of BSS Plus against vitreous biochemical data from non-diabetics and diabetics 
 
Current vitreous results 
 
 
Diabetic Mean vitreous  Reported  Difference Ratio of means 
Unpaired i  Q(i/m) status  value concentration between means
  (BSS Plus: t-test  (m = 16) 
in BSS Plus current data)







= 15) 160 12.53 ± 0.8937 
14.25 ± 0.8539 
—0.9200 ± 0.2644 
—0.5000 ± 0.1642 
7.533 ± 0.6752 
9.417 ± 0.6450 
—0.2740 ± 0.1310 





2.573 ± 0.1742 
1.350 ± 0.2572 
—3.602 ± 0.3144 
—4.433 ± 0.2042 
14.50 ± 1.708 
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*P < 0.05, **P < 0.01, ***P < 0.001.  †Statistically significant after controlling for false discovery rate. 
i, P value rank; m, total number of significance tests (16); n, subgroup sample size; P, P value of independent-
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